Skip to main navigation Skip to search Skip to main content

Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147] (International Journal for Parasitology: Drugs and Drug Resistance (2021) 16 (140–147), (S221132072100021X), (10.1016/j.ijpddr.2021.05.002))

  • Philip T. LoVerde
  • , Sevan N. Alwan
  • , Alexander B. Taylor
  • , Jayce Rhodes
  • , Frédéric D. Chevalier
  • , Timothy Jc Anderson
  • , Stanton F. McHardy
  • University of Texas Health Science Center at San Antonio
  • University of Texas at San Antonio
  • Southwest Foundation for Biomedical Research

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the acknowledgements of SNA were funded by SABER IRACDA program 2k12GM111726 was inadvertently left out of the article.

Original languageEnglish
Pages (from-to)103
Number of pages1
JournalInternational Journal for Parasitology: Drugs and Drug Resistance
Volume18
DOIs
StatePublished - Apr 2022

Fingerprint

Dive into the research topics of 'Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147] (International Journal for Parasitology: Drugs and Drug Resistance (2021) 16 (140–147), (S221132072100021X), (10.1016/j.ijpddr.2021.05.002))'. Together they form a unique fingerprint.

Cite this